What Payers Will Demand From Evidence in 2026

The start of a new year brings more than refreshed planning cycles, it brings a reset in payer expectations. As 2026 gets underway, payers are signaling that the evidence bar is rising. Traditional endpoints alone are no longer sufficient. Retrospective analyses...

AI & Predictive Modeling Are Transforming HEOR

For years, HEOR teams have focused on describing the past: analyzing retrospective claims, EMR data, and trial endpoints to understand treatment patterns and cost trajectories. But the next competitive edge in market access won’t come from explaining what happened. It...